Dr. Christopher Rogers was honored to speak at the April 2021 La Jolla Golden Triangle Rotary Club meeting. Topics of the lecture included a history of stem cell therapy in San Diego and an update on FDA-approved clinical trials for knee osteoarthritis. To see a copy of the lecture, visit the San Diego Orthobiologics Medical Group YouTube channel or view the video linked below!
Stem cell therapies have the potential to treat many medical conditions that were previously untreatable. But, despite their enormous promise, stem cell therapies are only in the early stages of clinical development. For the past two decades, hundreds of scientific studies have been conducted, but much more work is required to prove the safety and efficacy of these treatments.
Recently, the FDA posted a warning to patients about the rising number of illegal stem cell clinics. In addition, a newly released short film documents the fraudulent and illegal activity of these stem cell clinics. Experts in the field were interviewed and shared their experience, warning patients about the fraud and abuse that is rampant in the United States.
Unscrupulous healthcare providers sell illegal birth tissue products and fraudulently promote them as “stem cell therapy”. These products include amniotic fluid, umbilical cord blood and exosomes. They are not FDA approved because they have not been tested for safety or efficacy. Physicians are not permitted to use them. In fact, patients have been harmed by them. And not surprisingly, none of these products have been shown to contain actual live stem cells.
The physicians at San Diego Orthobiologics Medical Group support the experts and would like to educate patients about the risks of using illegal stem cell products. We only use FDA compliant cell therapies for our patients. We do not use birth tissue products because they have not been tested for safety or efficacy and are not permitted by the FDA. Our physicians are recognized leaders in the field of Orthobiologics, conduct FDA approved stem cell research and have published in the peer-reviewed scientific literature.
To learn more, please download our free E-book, The Patient’s Guide to Stem Cells.
Dr. Christopher Rogers, founder of San Diego Orthobiologics Medical Group (SDOMG) and medical director for Personalized Stem Cells, Inc. (PSC), is pleased to announce that they have obtained FDA approval to treat patients with severe COVID-19 using stem cells.
In record time, Personalized Stem Cells, Inc. has received approval from the U.S. Food and Drug Administration to conduct a clinical trial of stem cells for the treatment of patients with severe COVID-19 (1). Stem cell therapy has already shown encouraging results in studies conducted in Spain, Israel, and China. Dr. Rogers and his coauthors recently published a landmark peer-reviewed scientific article on the rationale behind the use of stem cells to treat COVID-19 (2). Support from entire team at SDOMG and PSC was critical to achieving this exciting accomplishment. We are eager to initiate this clinical trial and demonstrate the safety and efficacy of this innovative and promising therapy.
Resources
1) WFMJ: Personalized Stem Cells Receives FDA Approval to Treat COVID-19 Patients
FDA has sent warning letters to companies that process, distribute and offer umbilical cord blood derived products and unapproved stem cell products to patients. FDA also issued a safety alert about exosome products which are not FDA approved and had multiple recent reports of serious adverse events associated with its use.
Public Safety Notification on Exosome Products: https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/public-safety-notification-exosome-products
FDA sends warning to companies for offering unapproved umbilical cord blood products that may put patients at risk: https://www.fda.gov/news-events/press-announcements/fda-sends-warning-companies-offering-unapproved-umbilical-cord-blood-products-may-put-patients-risk